OUP Management as of March 31, 2022
Portfolio Holdings for OUP Management
OUP Management holds 16 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
ionQ Common Stock (IONQ) | 22.5 | $30M | 2.3M | 12.76 | |
Centessa Pharmaceuticals Sponsored ADS (CNTA) | 20.1 | $26M | 2.9M | 8.97 | |
PMV Pharmaceuticals Common Stock (PMVP) | 15.7 | $21M | 989k | 20.82 | |
Aerovate Therapeutics Common Stock (AVTE) | 8.4 | $11M | 604k | 18.33 | |
DICE Therapeutics Common Stock | 7.8 | $10M | 537k | 19.13 | |
Cyteir Therapeutics Common Stock | 7.1 | $9.3M | 2.5M | 3.77 | |
Evolv Technologies Holdings Common Stock (EVLV) | 3.7 | $4.8M | 1.8M | 2.65 | |
eFFECTOR Therapeutics Common Stock | 3.1 | $4.1M | 1.0M | 4.01 | |
Precision BioSciences Common Stock | 2.6 | $3.5M | 1.1M | 3.08 | |
Landos Biopharma Common Stock | 2.1 | $2.7M | 1.8M | 1.48 | |
Vor Biopharma Common Stock (VOR) | 1.7 | $2.3M | 375k | 6.04 | |
Spero Therapeutics Common Stock (SPRO) | 1.6 | $2.2M | 249k | 8.70 | |
Graphite Bio Common Stock | 1.6 | $2.1M | 406k | 5.10 | |
Sera Prognostics Common Stock (SERA) | 1.0 | $1.3M | 338k | 3.79 | |
Selecta Biosciences Common Stock (RNAC) | 0.8 | $1.1M | 863k | 1.23 | |
Homology Medicines Common Stock | 0.1 | $195k | 64k | 3.05 |